Genetical Mutation of Hromosome 1 - Morbus Gaucher Type I

Authors

  • Amira Redžić Katedra za biologiju sa humanom genetikom Medicinskog fakulteta Univerziteta u Sarajevu, BiH
  • Fatima Begić Kantonalna bolnica „Dr. Irfan Ljubijankić“, Bihać, BiH

DOI:

https://doi.org/10.5644/Radovi.368

Abstract

No abstract available.

References

Grabowski, A.G. (1998): A cornparasion of imiglucerase and aglucerase therapy for Type 1 Guacher disease. Gaucher Clinical Perspectives — Molecular medicine & Therapeutics, 6(1): 1-4.

Kicic, M., Krajincanic, Branka (1989): Medicinska genetika. Zavod za udžbenike i nastavna sredstva - Beograd, 1-160.

Kingama, W., Rosenberg, M, Richards, S.M. (1998): Antibody formation in patients receiving imiglucerase and impact on safeti and clinical response. Gaucher Clinical Perspectives - Molecular medicine&Therapeutics, 6(1): 8-11.

McKusick, V.A. (1982): Mendelian inheritance in man. Catalogs of autosomal, dominant, autosomal recessive, and X-linked phenotypes. Sixth edition. The Johns Hopkins University Press, Baltimore and London.

Pastores, G.M. (1998): Recombinant enzyme therapy for Gaucher disease: long-term clinical experience and therapeutic outeomes with cross-over from alglucerose. Gauchcr Clinical Perspectives-Molecular medicine&Therapeutics, 6(1): 5-8.

Rice, E., Barranger, A. (1996): Laboratory diagnosis of end genetic counseling for Gaucher disease. Gaucher Clinical Perspectives – Molecular medicine&Therapeutics, 4(2): 1-4.

Downloads

Published

18.05.2003

Issue

Vol. 32 (2003): Radovi

Section

Case Report

License

Copyright (c) 2026 Amira Redžić, Fatima Begić

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

Genetical Mutation of Hromosome 1 - Morbus Gaucher Type I. (2003). Acta Medica Academica, 32, 251-259. https://doi.org/10.5644/Radovi.368

Most read articles by the same author(s)